Jay Gross, MD
Cardiovascular Disease · Bronx, NYNPI 1750470092
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,320 of the $8,379 with a category attached, or 63.5%. 10 manufacturers reported payments, led by Medtronic at 58.0% of the total. 2025 is the largest year on record at $4,436, 8.2 times the $542 reported in 2019.
Across 80 payments — averaging $104.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$1K
- Biosense Webster, Inc.$1K
- Biotronik Inc.$370
- Boston Scientific$317
- Philips North America LLC$240
- plus $371 from 4 others
What the payments were for
- Travel & lodging$3,05937%
- Food & beverage$5,32063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 35 | $4,857 |
| Abbott | 12 | $1,144 |
| Biosense Webster, Inc. | 9 | $1,080 |
| Biotronik Inc. | 7 | $370 |
| Boston Scientific | 5 | $317 |
| Philips North America LLC | 4 | $240 |
| Impulse Dynamics (USA) Inc. | 1 | $155 |
| Angiodynamics, Inc. | 1 | $115 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $87 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$1,047
- AVEIR$742
- EVERA MRI XT DR SURESCAN$485
- NUVISION ICE CATHETER$363
- OPTIMIZER$310
- AURORA EV-ICD MRI SURESCAN$270
- ATTAIN COMMAND + SUREVALVE$166
- GENERAL - THERAPIES$150
- QDOT MICRO$141
- Claria MRI$121
- SQ RX PULSE GENERATOR$111
- DecaNav$110
- GlideLight$105
- Azure$103
- OCTARAY MAPPING CATHETER$101
How this compares
$8,379 in reported general payments places this provider in the 80th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $17,554 |
| Metoprolol Succinate | 11 | $112 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Bronx
- Luigi di BiaseBronx$978K
- Joseph HelftBronx$488K
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.